3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow Trigeminal Autonomic Cephalalgias: new trials by email Literature Review of Trigeminal Autonomic Cephalalgias trials Research Report on Trigeminal Autonomic Cephalalgias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache Fremanezumab - Cluster Headache | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 275 | 2017-04-27 | 2021-11-09 |
| A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Fremanezumab, Placebo - Episodic Cluster Headache | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 169 | 2017-01-19 | 2021-11-09 |
| A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH) Fremanezumab, Placebo - Chronic Cluster Headache | Phase 3 | Terminated | Teva Branded Pharmaceutical Products R&D, Inc. | 259 | 2017-01-17 | 2021-11-09 |
Cluster Headache (3)
Brain Diseases (3) · Central Nervous System Diseases (3) · Headache Disorders (3) · Headache Disorders, Primary (3) · Nervous System Diseases (3)
fremanezumab (3)
Teva Branded Pharmaceutical Products R&D, Inc. (3)
Australia (3) · Canada (3) · Finland (3) · Germany (3) · Israel (3) · Italy (3) · Netherlands (3) · Poland (3) · Spain (3) · Sweden (3) · United Kingdom (3) · United States (3)
2016 (3)